KP Tissue Inc
TSX:KPT

Watchlist Manager
KP Tissue Inc Logo
KP Tissue Inc
TSX:KPT
Watchlist
Price: 10.74 CAD 0.28% Market Closed
Market Cap: CA$107.6m

Wall Street
Price Targets

KPT Price Targets Summary
KP Tissue Inc

Wall Street analysts forecast KPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KPT is 11.73 CAD with a low forecast of 11.11 CAD and a high forecast of 12.6 CAD.

Lowest
Price Target
11.11 CAD
3% Upside
Average
Price Target
11.73 CAD
9% Upside
Highest
Price Target
12.6 CAD
17% Upside
KP Tissue Inc Competitors:
Price Targets
WDH
Waterdrop Inc
41% Upside
LFG
Leone Film Group SpA
50% Upside
AVIR
Atea Pharmaceuticals Inc
42% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
37%
Average Beat
N/A
Past Growth
0% / Year
Estimated Growth
Estimates Accuracy
37%
Average Beat

The compound annual growth rate of KP Tissue Inc's net income for the next 2 years is 0%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is KPT's stock price target?
Price Target
11.73 CAD

According to Wall Street analysts, the average 1-year price target for KPT is 11.73 CAD with a low forecast of 11.11 CAD and a high forecast of 12.6 CAD.

What is KP Tissue Inc's Net Income forecast?
Projected CAGR
0%

The compound annual growth rate of KP Tissue Inc's net income for the next 2 years is 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett